Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers
Biomarkers are revolutionizing oncology drug development, driving modern precision medicine approaches, targeted clinical trial recruitment strategies, and critical decision-making at early R&D inflection points.
